Answers are grounded in this paper and cite their sources.
Drugs removed from the US market after approval can be either discontinued by the manufacturer or withdrawn by the FDA. However, a systematic overview is currently lacking. This minireview provides a comprehensive analysis of removed drugs, identifies patterns regarding drug classes, indications, adverse effects, and scientific interest, and compares US removals with the EU and FDA boxed warnings. A total of 166 drugs were removed between 1955 and 2026, including 88 discontinued and 78 withdrawn drugs. Removed drugs represented a wide range of therapeutic fields, with certain drug classes occurring repeatedly, particularly COX inhibitors and fluoroquinolones. Market removals were frequently associated with serious adverse effects such as hepatotoxicity, cardiotoxicity, and hematologic toxicity. The prominent drug classes and adverse effect categories also occurred frequently among drugs carrying boxed warnings. While withdrawn drugs were typically banned by the FDA because of severe safety concerns, discontinued drugs were often removed because of commercial decisions or obsolescence, sometimes in combination with safety considerations. The analysis of publication peaks showed that for most drugs scientific interest peaked prior to market removal, while in other cases publication peaks occurred around or after withdrawal, indicating renewed scientific interest. Drug removals from the US market represent a heterogeneous group of drugs, indications, and underlying causes. While withdrawals and discontinuations differ in their regulatory implications, they share overlapping characteristics and safety considerations. Integration of EU availability and FDA boxed warning comparisons highlights international differences and patterns requiring precautionary attention, with recurring drug classes and adverse effects.
No takes yet. Share an insight, caveat, or question.
Bindel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: